Clinical Trial Update: Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of Lapaquistat acetate in combination with simvastatin in adults with primary dyslipidemia/hypercholesterolemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED